Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative pain control with intravenous parecoxib versus oral etoricoxib in ACL reconstruction
TCTR20230916002Phase 3Enrolling by invitation
- Sponsor
- Faculty of Medicine, Prince of Songkhla University
- Start
- Sep 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of parecoxib, etoricoxib in postoperative pain, sponsored by Faculty of Medicine, Prince of Songkhla University. Started Sep 2023; status: enrolling by invitation.
02
Drugs
parecoxibetoricoxib
03
Conditions
postoperative pain
Beyond the preview
Go deeper on TCTR20230916002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230916002.